Autoantibodies in Atrial Fibrillation—State of the Art
Open Access
- 17 January 2023
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (3) , 1852
Abstract
Atrial fibrillation (AF) is the most common type of cardiac arrhythmia. To date, a lot of research has been conducted to investigate the underlying mechanisms of this disease at both molecular and cellular levels. There is increasing evidence suggesting that autoimmunity is an important factor in the initiation and perpetuation of AF. Autoantibodies are thought to play a pivotal role in the regulation of heart rhythm and the conduction system and, therefore, are associated with AF development. In this review, we have summarized current knowledge concerning the role of autoantibodies in AF development as well as their prognostic and predictive value in this disease. The establishment of the autoantibody profile of separate AF patient groups may appear to be crucial in terms of developing novel treatment approaches for those patients; however, the exact role of various autoantibodies in AF is still a matter of ongoing debate.Keywords
This publication has 56 references indexed in Scilit:
- Response of circulating heat shock protein 70 and anti-heat shock protein 70 antibodies to catheter ablation of atrial fibrillationJournal of Translational Medicine, 2013
- Predictive value of pre-procedural autoantibodies against M2-muscarinic acetylcholine receptor for recurrence of atrial fibrillation one year after radiofrequency catheter ablationJournal of Translational Medicine, 2013
- Autoantibodies and the Risk of Cardiovascular EventsThe Journal of Rheumatology, 2009
- Activating Autoantibodies to the Beta-1 Adrenergic and M2 Muscarinic Receptors Facilitate Atrial Fibrillation in Patients With Graves' HyperthyroidismJACC, 2009
- Atrial Fibrillation Begets Atrial FibrillationCirculation: Arrhythmia and Electrophysiology, 2008
- Effects of Autoantibodies against M2 Muscarinic Acetylcholine Receptors on Rabbit Atria in vivoCardiology, 2008
- Atrial fibrosis and the mechanisms of atrial fibrillationHeart Rhythm, 2007
- IgGs and Mabs against the β2-adrenoreceptor block A-V conduction in mouse hearts: A possible role in the pathogenesis of ventricular arrhythmiasJournal of Molecular and Cellular Cardiology, 2006
- Autoantibodies against M2-muscarinic acetylcholine receptors: new upstream targets in atrial fibrillation in patients with dilated cardiomyopathyEuropean Heart Journal, 2004
- Epidemiologic Features of Chronic Atrial FibrillationNew England Journal of Medicine, 1982